Cardiff Oncology

Forecast & Rating7 analysts currently cover Cardiff Oncology, with about 42.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $5.81, about 513.5% upside from the current price of $0.95. Price targets range from $1.20 to $12.00 — a wide spread, showing clear disagreement over just how much Cardiff Oncology can rise. For you, this means institutional views on Cardiff Oncology are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 15, 2026; for reference only and not investment advice.